Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock

被引:109
|
作者
Soriano, FG [1 ]
Nogueira, AC
Caldini, EG
Lins, MH
Teixeira, AC
Cappi, SB
Lotufo, PA
Bernik, MMS
Zsengellér, Z
Chen, M
Szabó, C
机构
[1] Univ Sao Paulo, Univ Hosp, Disciplina Emergencias Clin, BR-05508 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Dept Anat Patol, BR-05508 Sao Paulo, Brazil
[3] Inotek Pharmaceut Corp, Beverly, MA USA
[4] Semmelweis Univ, Sch Med, Dept Human Physiol & Expt Res, Budapest, Hungary
关键词
sepsis; poly(ADP-ribose) polymerase; peroxynitrite; heart dysfunction; oxidative and nitrosative stress;
D O I
10.1097/01.CCM.0000206470.47721.8D
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. Sepsis is associated with increased production of superoxide and nitric oxide, with consequent peroxynitrite generation. Cardiodepression is induced in the heart during oxidative stress associated with septic shock. Oxidative and nitrosative stress can lead to activation of the nuclear enzyme poly(adenosine 5'-diphosphate [ADP]-ribose) polymerase (PARP), with subsequent loss of myocardial contractile function. The aim of the study was to investigate whether cardiodepression found in septic patients is associated with plasma markers of myocardial necrosis and with myocardial PARP activation. Design: Prospective and observational study. Setting. University hospital intensive care unit for clinical and surgical patients. Patients: Twenty-five patients older than 18 yrs presenting with severe sepsis or septic shock. Patients with history of chronic heart failure, cancer, coronary artery disease, diabetes, or acquired immune deficiency syndrome were excluded. Interventions. Patients were followed for 28 days, and biochemical and hemodynamic data were collected on days 1, 3, and 6 of sepsis. The groups were survivors and nonsurvivors, defined only after the end of clinical patient evolution. Heart sections from patients who died were analyzed with hematoxylin-eosin and Picro Sirius-Red immunostaining and with electron microscopy. Measurements and Main Results. The study population included 25 individuals, of whom 12 (48%) died during the 6 days of follow-up. The initial data of the inflammation marker C-reactive protein and Acute Physiologic and Chronic Health. Evaluation severity were similar in both groups (nonsurvivors, 26 +/- 2; survivors, 24 +/- 5). Overall, an increase in plasma troponin level was related to increased mortality risk. In patients who died, significant myocardial damage was detected, and histologic analysis of heart sections showed inflammatory infiltration, increased collagen deposition, and derangement of mitochondrial cristae. Immunohistochemical staining for poly(ADP-ribose) (PAR), the product of activated PARP, was demonstrated in septic hearts. There was a positive correlation between PAR staining densitometry and troponin I (r(2) = 0.73; p < .05), and the correlation of PAR staining densitometry and left ventricular systolic stroke work index was r(2) = 0.33 (p = .0509). Conclusion: There is significant PARP activation in the hearts of septic patients with impaired cardiac function. We hypothesize that PARP activation may be partly responsible for the cardiac depression seen in humans with severe sepsis.
引用
收藏
页码:1073 / 1079
页数:7
相关论文
共 43 条
  • [21] Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase
    Korkmaz-Icoez, Sevil
    Radovits, Tamas
    Loganathan, Sivakkanan
    Li, Shiliang
    Ruppert, Mihaly
    Benke, Kalman
    Brlecic, Paige
    Szabo, Csaba
    Karck, Matthias
    Szabo, Gabor
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 51 (05) : 829 - 835
  • [22] Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite
    Huang, James
    Lin, Stephanie C.
    Nadershahi, Afshin
    Watts, Stephanie W.
    Sarkar, Rajabrata
    JOURNAL OF VASCULAR SURGERY, 2008, 47 (03) : 599 - 607
  • [23] The cytotoxic T lymphocyte protease granzyme A cleaves and inactivates poly(adenosine 5′-diphosphate-ribose) polymerase-1
    Zhu, Pengcheng
    Martinvalet, Denis
    Chowdhury, Dipanjan
    Zhang, Dong
    Schlesinger, Ann
    Lieberman, Judy
    BLOOD, 2009, 114 (06) : 1205 - 1216
  • [24] Poly(Adenosine 5′-Diphosphate-Ribose) Polymerase Inhibition Counteracts Multiple Manifestations of Experimental Type 1 Diabetic Nephropathy
    Drel, Viktor R.
    Xu, Weizheng
    Zhang, Jie
    Pavlov, Ivan A.
    Shevalye, Hanna
    Slusher, Barbara
    Obrosova, Irina G.
    ENDOCRINOLOGY, 2009, 150 (12) : 5273 - 5283
  • [25] Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition
    Audeh, M. William
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 307 - 316
  • [26] Expression of Poly (Adenosine Diphosphate-Ribose) Polymerase and p53 in Epithelial Ovarian Cancer and Their Role in Prognosis and Disease Outcome
    Godoy, Heidi
    Mhawech-Fauceglia, Paulette
    Beck, Amy
    Miller, Austin
    Lele, Shashikant
    Odunsi, Kunle
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (02) : 139 - 144
  • [27] Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation
    Shrikhande, G
    Khaodhiar, L
    Scali, S
    Lima, C
    Hubbard, M
    Dudley, K
    Ganda, O
    Ferran, C
    Veves, A
    JOURNAL OF VASCULAR SURGERY, 2006, 43 (04) : 760 - 770
  • [28] 5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct size
    Wayman, N
    McDonald, MC
    Thompson, AS
    Threadgill, MD
    Thiemermann, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 430 (01) : 93 - 100
  • [29] Activation of the peroxynitrite-poly(adenosine diphosphate-ribose) polymerase pathway during neointima proliferation:: A new target to prevent restenosis after endarterectomy
    Beller, CJ
    Radovits, T
    Kosse, J
    Gerö, D
    Szabó, C
    Szabó, G
    JOURNAL OF VASCULAR SURGERY, 2006, 43 (04) : 824 - 830
  • [30] The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes
    Pacher, P
    Liaudet, L
    Soriano, FG
    Mabley, JG
    Szabó, É
    Szabó, C
    DIABETES, 2002, 51 (02) : 514 - 521